This article was originally published in The Tan Sheet
Executive SummaryWalgreens has acquired the rights from Bristol-Myers Squibb to act as exclusive distributor of Theragran-M Advanced formula multivitamins, the company announces Sept. 19. "Over the last 50 years, Theragran multivitamins have earned significant customer trust and loyalty worldwide," Walgreens category manager Robert Bobber said. "The brand's strong heritage and reputation for promoting proper nutrition make it an excellent fit for Walgreens." Theragran-M will retain its original packaging, with the addition of "exclusively distributed by Walgreens" added to the label, according to a company spokesperson. The brand, which BMS retired in 2005, will be available in Walgreens in October...
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November 2019.